Markets:

Overview

News

Currencies

International

Treasuries

Novo Integrated Sciences, Inc. - Common Stock (NQ:NVOS)

0.1490 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Novo Integrated Sciences, Inc. - Common Stock

< Previous 1 2 3 Next >

Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results

December 18, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results

July 19, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program

July 18, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program

June 13, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million

June 06, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note

June 03, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products

June 05, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program

May 31, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program

May 30, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results

April 15, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement

April 11, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

March 26, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.

February 21, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note

February 20, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Appoints New President

February 16, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results

January 22, 2024

From Novo Integrated Sciences, Inc.

Via Business Wire

Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences

December 19, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results

December 14, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India

December 05, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

November 24, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval

December 04, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Announces Reverse Stock Split

November 06, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days

November 06, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond

November 03, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences’ Board of Directors Approves $5 Million Stock Repurchase Program

October 24, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Provides Update on Certain Current Events

October 06, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Signs Master Collateral Transfer Agreement

September 28, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Provides Update on Certain Current Actions and Events

September 21, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences’ IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health

September 13, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Provides Update on Potential Share Repurchase Program

September 08, 2023

From Novo Integrated Sciences, Inc.

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.